# A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds

> **NCT03932045** · NA · COMPLETED · sponsor: **Samyang Biopharmaceuticals Corporation** · enrollment: 59 (actual)

## Conditions studied

- Nasolabial Folds

## Interventions

- **DEVICE:** SYB Filler (SF-01)
- **DEVICE:** Ellansé M

## Key facts

- **NCT ID:** NCT03932045
- **Lead sponsor:** Samyang Biopharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-08
- **Primary completion:** 2020-09-15
- **Final completion:** 2022-08-12
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2022-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03932045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03932045, "A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03932045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*